EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

8-Epixanthatin Suppresses RANKL-Induced Osteoclast Differentiation via Inhibition of NF-κB and MAPK Signaling

Lifang Zhang, Vishwa Deepak iD

International Journal of Molecular Sciences · 17.04.2026 · 27 (8) · 3578

DOI: 10.3390/ijms27083578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.04.2026. Verfasst von Lifang Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Osteoimmunology and Drug Discovery Research Group, Department of Biology, College of Science, Mathematics and Technology, Wenzhou-Kean University, 88…. Hauptthemen laut MEDLINE: Osteoclasts, RANK Ligand, Cell Differentiation, NF-kappa B. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wenzhou-Kean University, International Frontier Interdisciplinary Research Institute, WKU-ISRG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoclast hyperactivity represents a central mechanism in pathological bone destruction, underscoring the importance of discovering novel anti-resorptive compounds. In this study, we present early-stage evidence that 8-Epixanthatin can inhibit osteoclast differentiation induced by receptor activator of nuclear factor kappa-B ligand (RANKL). 8-Epixanthatin exhibited no significant cytotoxicity at the concentrations used for osteoclast differentiation studies. The compound showed concentration-dependent reductions in TRAP-positive multinucleated osteoclasts, with an IC50 value of 2.3 μM. Our mechanistic investigations revealed that 8-Epixanthatin interferes with RANKL-activated signaling networks, particularly nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase (MAPK) cascades. Collectively, these observations identify 8-Epixanthatin as a promising lead structure for anti-osteoclast drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsRANK LigandCell DifferentiationNF-kappa BMitogen-Activated Protein KinasesMAP Kinase Signaling SystemAnimalsMiceSignal Transduction

Stichwörter der Autor:innen

bone resorptionmitogen-activated protein kinase (MAPK)natural compoundsnuclear factor κB (NF-κB)osteoclast differentiationosteoporosisreceptor activator of nuclear factor kappa-B ligand (RANKL)

Substanzen

RANK LigandNF-kappa BMitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Osteoimmunology and Drug Discovery Research Group, Department of Biology, College of Science, Mathematics and Technology, Wenzhou-Kean University, 88 Daxue Road, Wenzhou 325060, China.
  • Dorothy and George Hennings College of Science, Mathematics and Technology, Kean University, 1000 Morris Ave, Union, NJ 07083, USA.
  • International Frontier Interdisciplinary Research Institute (IFIRI), Wenzhou-Kean University, Wenzhou 325060, China.
  • Wenzhou Municipal Key Laboratory for Applied Biomedical and Biopharmaceutical Informatics, Wenzhou-Kean University, Ouhai, Wenzhou 325060, China.
  • Zhejiang Bioinformatics International Science and Technology Cooperation Center, Wenzhou-Kean University, Ouhai, Wenzhou 325060, China.
  • Zhejiang-Malaysia Joint Laboratory for Rare Medicinal Resources, Wenzhou-Kean University, 88 Daxue Road, Ouhai, Wenzhou 325060, China.

ORCID-Profile: Vishwa Deepak

Förderung

  • Wenzhou-Kean University
  • International Frontier Interdisciplinary Research Institute
  • WKU-ISRG

Zitieren

APA

Zhang, L., & Deepak, V. (2026). 8-Epixanthatin Suppresses RANKL-Induced Osteoclast Differentiation via Inhibition of NF-κB and MAPK Signaling. International Journal of Molecular Sciences, 27(8), 3578. https://doi.org/10.3390/ijms27083578

Vancouver

Zhang L, Deepak V. 8-Epixanthatin Suppresses RANKL-Induced Osteoclast Differentiation via Inhibition of NF-κB and MAPK Signaling. International Journal of Molecular Sciences. 2026;27(8):3578. doi:10.3390/ijms27083578

BibTeX
@article{Zhang2026,
  author = {Zhang, Lifang and Deepak, Vishwa},
  title = {8-Epixanthatin Suppresses RANKL-Induced Osteoclast Differentiation via Inhibition of NF-κB and MAPK Signaling},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {8},
  pages = {3578},
  doi = {10.3390/ijms27083578}
}
Kostenlos starten →